Maria (Cecilia) Soriano, Group President, Infusion Therapies & Technologies (ITT) and Pharmaceuticals at Baxter International Inc.. Biography, career history and compensation sourced from SEC proxy filings.
About
Maria Cecilia Soriano is Group President, Infusion Therapies & Technologies & Pharmaceuticals at Baxter International. She was appointed to her current role in 2025 after serving as President, Infusion Therapies & Technologies since 2023.
Prior to joining Baxter, Ms. Soriano served in roles of increasing responsibility at Becton, Dickinson and Company, including as Global Vice President and General Manager, Microbiology from 2020 to 2023; U.S. Vice President and General Manager, Diabetes Care; Senior Vice President, Global Marketing and Strategy; and Vice President, Strategic Marketing.
Previously, she worked at Johnson & Johnson, The Coca-Cola Company and Citibank, N.A. Ms. Soriano currently serves as a member of the board of directors of ScionHealth.
Roles
Baxter International Inc.
Group President, Infusion Therapies & Technologies (ITT) and Pharmaceuticals · Current role
2025–present
Baxter International Inc.
President, Infusion Therapies & Technologies
2023 to 2025
Becton, Dickinson and Company
Global Vice President and General Manager, Microbiology · Earlier roles included U.S. VP and GM, Diabetes Care; SVP, Global Marketing and Strategy; and VP, Strategic Marketing.
2020 to 2023
Johnson & Johnson; The Coca-Cola Company; Citibank, N.A.
Prior roles
—
Becton Dickinson (BD)
Global VP/General Manager, Microbiology
—
Johnson & Johnson
Marketing, commercial and business leadership roles